Mark L. Berch

Array ( [id] => 1175880 [patent_doc_number] => 06747016 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-08 [patent_title] => 'Substituted purine derivatives as inhibitors of cell adhesion' [patent_app_type] => B1 [patent_app_number] => 10/030290 [patent_app_country] => US [patent_app_date] => 2002-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18021 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1208 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/747/06747016.pdf [firstpage_image] =>[orig_patent_app_number] => 10030290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 725085 [patent_doc_number] => 07045618 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-16 [patent_title] => 'Cefpodixime proxetil' [patent_app_type] => utility [patent_app_number] => 10/469330 [patent_app_country] => US [patent_app_date] => 2002-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1720 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/045/07045618.pdf [firstpage_image] =>[orig_patent_app_number] => 10469330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6082605 [patent_doc_number] => 20020082269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'A1 adenosine receptor antagonists' [patent_app_type] => new [patent_app_number] => 10/083836 [patent_app_country] => US [patent_app_date] => 2002-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3450 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20020082269.pdf [firstpage_image] =>[orig_patent_app_number] => 10083836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6383089 [patent_doc_number] => 20020120136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'Method of preparing cephalosporins using 4-hydroxyphenylglycine derivatives' [patent_app_type] => new [patent_app_number] => 10/083777 [patent_app_country] => US [patent_app_date] => 2002-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4070 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20020120136.pdf [firstpage_image] =>[orig_patent_app_number] => 10083777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6329740 [patent_doc_number] => 20020198205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-26 [patent_title] => 'Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions' [patent_app_type] => new [patent_app_number] => 10/081826 [patent_app_country] => US [patent_app_date] => 2002-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55248 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20020198205.pdf [firstpage_image] =>[orig_patent_app_number] => 10081826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7281552 [patent_doc_number] => 20040063929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Beta-lactam compounds process for reproducing the same and serum cholesterol-lowering agents containing the same' [patent_app_type] => new [patent_app_number] => 10/450171 [patent_app_country] => US [patent_app_date] => 2003-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16234 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063929.pdf [firstpage_image] =>[orig_patent_app_number] => 10450171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1229275 [patent_doc_number] => 06696566 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-24 [patent_title] => '6-substituted pyrido-pyrimidines' [patent_app_type] => B2 [patent_app_number] => 10/073845 [patent_app_country] => US [patent_app_date] => 2002-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37105 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 184 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/696/06696566.pdf [firstpage_image] =>[orig_patent_app_number] => 10073845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6210012 [patent_doc_number] => 20020072513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-13 [patent_title] => 'Process for the production of clavulanic acid salts' [patent_app_type] => new [patent_app_number] => 10/071364 [patent_app_country] => US [patent_app_date] => 2002-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1965 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20020072513.pdf [firstpage_image] =>[orig_patent_app_number] => 10071364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6751012 [patent_doc_number] => 20030045533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Phosphodiesterase 4 inhibitors' [patent_app_type] => new [patent_app_number] => 10/067996 [patent_app_country] => US [patent_app_date] => 2002-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17526 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20030045533.pdf [firstpage_image] =>[orig_patent_app_number] => 10067996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1357749 [patent_doc_number] => 06576761 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-10 [patent_title] => 'Process for the preparation of cephem compounds' [patent_app_type] => B1 [patent_app_number] => 10/049048 [patent_app_country] => US [patent_app_date] => 2002-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5410 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 347 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/576/06576761.pdf [firstpage_image] =>[orig_patent_app_number] => 10049048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6048709 [patent_doc_number] => 20020169175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'Pharmaceutically acceptable salts of heterocyclic compounds' [patent_app_type] => new [patent_app_number] => 10/067094 [patent_app_country] => US [patent_app_date] => 2002-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29739 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20020169175.pdf [firstpage_image] =>[orig_patent_app_number] => 10067094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6814284 [patent_doc_number] => 20030073834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Purine compounds having PDE IV inhibitory activity and methods of synthesis' [patent_app_type] => new [patent_app_number] => 10/062280 [patent_app_country] => US [patent_app_date] => 2002-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11688 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20030073834.pdf [firstpage_image] =>[orig_patent_app_number] => 10062280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6675024 [patent_doc_number] => 20030060627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => '8-Phenyl-6, 9-dihydro-[1,2,4] triazolo[3,4-i]purin-5-one derivatives' [patent_app_type] => new [patent_app_number] => 10/057847 [patent_app_country] => US [patent_app_date] => 2002-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25188 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20030060627.pdf [firstpage_image] =>[orig_patent_app_number] => 10057847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847753 [patent_doc_number] => 20030166920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Prismatic supramolecules' [patent_app_type] => new [patent_app_number] => 10/056269 [patent_app_country] => US [patent_app_date] => 2002-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10128 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166920.pdf [firstpage_image] =>[orig_patent_app_number] => 10056269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6159579 [patent_doc_number] => 20020147333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => '2-(pyrazol-3-yl)carbapenem derivatives' [patent_app_type] => new [patent_app_number] => 10/055489 [patent_app_country] => US [patent_app_date] => 2002-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32129 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20020147333.pdf [firstpage_image] =>[orig_patent_app_number] => 10055489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 558827 [patent_doc_number] => 07157448 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-02 [patent_title] => 'Acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same' [patent_app_type] => utility [patent_app_number] => 10/450780 [patent_app_country] => US [patent_app_date] => 2002-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21932 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/157/07157448.pdf [firstpage_image] =>[orig_patent_app_number] => 10450780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1282938 [patent_doc_number] => 06642377 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-04 [patent_title] => 'Process for the preparation of basic antibiotic-inorganic acid addition salts and intermediate oxalates' [patent_app_type] => B1 [patent_app_number] => 10/030909 [patent_app_country] => US [patent_app_date] => 2002-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5871 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/642/06642377.pdf [firstpage_image] =>[orig_patent_app_number] => 10030909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6537151 [patent_doc_number] => 20020193353 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => '2-hydroxymethylcyclopropylidenemethylpurines and -pyrimidines as antiviral agents' [patent_app_type] => new [patent_app_number] => 10/047202 [patent_app_country] => US [patent_app_date] => 2002-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 22468 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20020193353.pdf [firstpage_image] =>[orig_patent_app_number] => 10047202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 833636 [patent_doc_number] => 07396926 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-08 [patent_title] => 'Beta-lactamase substrates having phenolic ethers' [patent_app_type] => utility [patent_app_number] => 10/044486 [patent_app_country] => US [patent_app_date] => 2002-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9178 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/396/07396926.pdf [firstpage_image] =>[orig_patent_app_number] => 10044486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 695880 [patent_doc_number] => 07071330 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-04 [patent_title] => 'Process for carbapenem synthesis' [patent_app_type] => utility [patent_app_number] => 10/466876 [patent_app_country] => US [patent_app_date] => 2002-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3301 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/071/07071330.pdf [firstpage_image] =>[orig_patent_app_number] => 10466876 [rel_patent_id] =>[rel_patent_doc_number] =>)